Target intelligence / Profile preview

HLTF antisense RNA 1 (HLTF-AS1)

Target
HLTF-AS1
Molecular classification
Long non-coding RNA (lncRNA), antisense lncRNA, Other
01

Overview

HLTF antisense RNA 1 (HLTF-AS1) is a long non-coding RNA transcribed from the DNA strand opposite to the HLTF gene. Antisense lncRNAs such as HLTF-AS1 may regulate the expression of the corresponding protein-coding sense gene through both epigenetic and post-transcriptional mechanisms. This class of RNA can modulate tumor cell behavior, including proliferation, apoptosis, migration, and chemoresistance, but HLTF-AS1 specifically has not yet been deeply characterized for these functions or as a therapeutic target. The value of antisense lncRNAs is emerging in cancer research, where they are being studied for roles in gene expression modulation and as possible candidates for intervention, although there are as yet no approved drugs or clinical biomarkers specifically targeting HLTF-AS1. HLTF antisense RNA 1 is distinct from the HLTF gene itself, which encodes the Helicase-like transcription factor, a protein with tumorigenic and genome stability functions. Current knowledge mostly extrapolates the general function of antisense lncRNAs rather than HLTF-AS1 specifically, as comprehensive characterization of HLTF-AS1 is lacking in the literature.

Other names
HLTF antisense RNA 1 (non-protein coding)HLTF-AS1
02

Biological functions

Regulation of gene expression (acts on HLTF sense gene by complementary sequence interaction)Modulation of mRNA stability (can form RNA duplexes with sense mRNA, influencing half-life and translation)Chromatin remodeling (recruits modifying enzymes to sense gene promoter)
03

Disease associations

Cancer (antisense lncRNAs including HLTF-AS1 are implicated in tumor proliferation, suppression, migration, and invasion, depending on context)Other (can affect chemoresistance and radioresistance in cancer, but specific roles of HLTF-AS1 require further confirmation)

Beyond the preview

Go deeper on HLTF antisense RNA 1 (HLTF-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HLTF antisense RNA 1 (HLTF-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call